AnteoTech Ltd
- Country
- 🇦🇺Australia
- Ownership
- -
- Employees
- 40
- Market Cap
- -
- Introduction
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)
- Conditions
- SARS-CoV-2 Infection
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- AnteoTech Ltd
- Target Recruit Count
- 599
- Registration Number
- NCT05618561
- Locations
- 🇭🇷
Institut Virion, Split, Croatia
🇬🇷Laiko General Hospital, Athens, Greece
🇪🇸Centro de Salud Fuentes Norte, Zaragoza, Aragón, Spain